Stonepine Capital Management as of March 31, 2016
Portfolio Holdings for Stonepine Capital Management
Stonepine Capital Management holds 19 positions in its portfolio as reported in the March 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| SciClone Pharmaceuticals | 26.6 | $23M | 2.0M | 11.00 | |
| Vanda Pharmaceuticals (VNDA) | 20.4 | $17M | 2.1M | 8.36 | |
| Vericel (VCEL) | 9.8 | $8.3M | 1.4M | 5.86 | |
| Pain Therapeutics | 9.3 | $7.9M | 3.5M | 2.23 | |
| Tobira Therapeutics Inc Common Stock Usd 0.0001 | 8.0 | $6.8M | 833k | 8.18 | |
| Cutera | 4.9 | $4.2M | 372k | 11.25 | |
| Sagent Pharmaceuticals | 4.8 | $4.1M | 333k | 12.17 | |
| Pernix Therapeutics Holdings | 4.0 | $3.4M | 3.2M | 1.05 | |
| Pernix Therapeutics Hldgs In debt | 2.8 | $2.3M | 6.0M | 0.39 | |
| Cti Biopharma | 2.3 | $2.0M | 3.7M | 0.53 | |
| Zeltiq Aesthetics | 2.2 | $1.9M | 70k | 27.16 | |
| Derma Sciences | 1.9 | $1.6M | 508k | 3.10 | |
| Recro Pharma | 1.7 | $1.4M | 237k | 5.97 | |
| BioSpecifics Technologies | 1.1 | $893k | 26k | 34.83 | |
| Raptor Pharmaceutical | 0.1 | $92k | 20k | 4.60 | |
| Sucampo Pharmaceuticals | 0.1 | $57k | 5.2k | 10.90 | |
| Biosante Pharmaceuticals (ANIP) | 0.1 | $56k | 1.7k | 33.94 | |
| Insys Therapeutics | 0.0 | $32k | 2.0k | 16.00 | |
| BioDelivery Sciences International | 0.0 | $28k | 8.5k | 3.29 |
